Hepatitis C Drug Market To Reach USD 26.9 Billion By 2032 Report By DataHorizzon Research
February 02, 2024 06:40 ET
|
DataHorizzon Research
Fort Collins, Colorado, Feb. 02, 2024 (GLOBE NEWSWIRE) -- The Hepatitis C Drug Market was valued at USD 20.8 Billion in 2022 and is anticipated to reach USD 26.9 Billion by 2032 at a CAGR of 2.7%. ...
Hepatitis C Drug Market Size & Share to Surpass $56.5 Billion by 2030 | Vantage Market Research
August 17, 2023 05:30 ET
|
Vantage Market Research
WASHINGTON, Aug. 17, 2023 (GLOBE NEWSWIRE) -- According to Vantage Market Research, the Global Hepatitis C Drug Market is estimated to be valued at USD 56.5 Billion by 2030 and is expected to...
Center for Disease Analysis Foundation Announces Receipt of an $8 Million Grant from Gilead Sciences to Relink Hepatitis B and C Patients to Care in the United States
July 20, 2023 12:00 ET
|
CDA Foundation
LAFAYETTE, Colo., July 20, 2023 (GLOBE NEWSWIRE) -- The Center for Disease Analysis Foundation (CDA Foundation) announced today that it received an $8 million grant from Gilead Sciences (Nasdaq:...
HepVu and NASTAD Release Inaugural Viral Hepatitis Surveillance Status Report
October 25, 2022 10:32 ET
|
HepVu
ATLANTA, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Today, HepVu and NASTAD released the first-ever assessment of viral hepatitis surveillance practices across U.S. jurisdictions, showing that while public...
Global Liver Fibrosis Treatment Market to Surpass US$ 33.4 Billion by 2030, Says Coherent Market Insights (CMI)
August 08, 2022 09:10 ET
|
CMI
Seattle, Aug. 08, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global liver fibrosis treatment market is estimated to be valued at US$ 14.7 billion in 2022 and is expected to...
HepVu Launches County-Level Hepatitis C-Related Mortality Data and Maps Visualizing Hepatitis C’s Impact on Americans at the Local-Level
March 03, 2021 12:44 ET
|
HepVu
ATLANTA, March 03, 2021 (GLOBE NEWSWIRE) -- Today, HepVu released new interactive maps visualizing U.S. county-level Hepatitis C-related mortality, illustrating how factors such as age and...
Cocrystal Pharma to Present at the H.C. Wainwright Global Life Sciences Virtual Conference
March 02, 2021 08:00 ET
|
Cocrystal Pharma, Inc.
BOTHELL, Wash., March 02, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel...
Cocrystal Pharma Inc.’s Structure-Based Technology has Demonstrated Broad Utility in Development of Antivirals
February 13, 2020 08:30 ET
|
Cocrystal Pharma, Inc.
– Positive preclinical and clinical data obtained to date in hepatitis C, influenza and norovirus programs bolster confidence in potential of our platform to address additional viral diseases,...
Actor Ernie Hudson to serve as national spokesperson for Think About the Link
December 16, 2019 12:48 ET
|
Prevent Cancer Foundation
Alexandria, Va., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Ernie Hudson is best known for his role in the 1984 cult classic, Ghostbusters; however few fans know him as two-time cancer survivor. Hudson was...
Hearts from Hepatitis C patients are safe to transplant, research shows
April 04, 2019 10:30 ET
|
International Society for Heart & Lung Transplantation
Orlando, Fla., April 04, 2019 (GLOBE NEWSWIRE) -- A growing body of research suggests that heart transplantation from donors with active Hepatitis C (HCV) is safe – and that the virus successfully...